P16301 Phosphatidylcholine-sterol acyltransferase MolNFT, Molecular NFT on GenesisL1

Phosphatidylcholine-sterol acyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeihb6ohh5433ktnbp2rqveygy4x6yt6p4zt7xtmb6lffvam6k5oqy4/metadata.json

IPFS of structure file:

bafybeiakg23is5x3w4shbgdcy3qjaol6uabkvjylo3mj2gasygz4pddjtq/AF-P16301-F1-model_v2.pdb

First NFT owner address (eip-55):

0x2F61dB7B2C9a82D9F38c269549C95103f50F9AEa

First NFT owner address (bech32):

genesis19asak7evn2pdnuuvy625nj23q06slxh2uv35fr

Current NFT ID #207919 owner (web3):

0x3298b100681D3A2372Bba3b2f282750dD71629B9

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
207919
Accession (UniProt):
P16301
Name::
Phosphatidylcholine-sterol acyltransferase
Experimental Method:
Predicted structure
Sequence source:
MUS MUSCULUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P16301 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P16301|LCAT_MOUSE Phosphatidylcholine-sterol acyltransferase OS=Mus musculus OX=10090 GN=Lcat PE=1 SV=2 MGLPGSPWQRVLLLLGLLLPPATPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNRLEAKLDKPDVVNWMCYRKTEDFFTIWLDFNLFLPLGVDCWIDNTRIVYNHSSGRVSNAPGVQIRVPGFGKTESVEYVDDNKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLAPHQQDEYYKKLAGLVEEMYAAYGKPVFLIGHSLGCLHVLHFLLRQPQSWKDHFIDGFISLGAPWGGSIKAMRILASGDNQGIPILSNIKLKEEQRITTTSPWMLPAPHVWPEDHVFISTPNFNYTVQDFERFFTDLHFEEGWHMFLQSRDLLERLPAPGVEVYCLYGVGRPTPHTYIYDHNFPYKDPVAALYEDGDDTVATRSTELCGQWQGRQSQPVHLLPMNETDHLNMVFSNKTLEHINAILLGAYRTPKSPAASPSPPPPE

P16301 AF NFT

MOLNFT AF v1

NFT data

MOLNFT P16301 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience